Cancer Epidemiology, Screening & Prevention

The Epidemiology of Cancer is the study of the factors affecting Cancer, as a way to conclude possible trends and causes. The study of Cancer Epidemiology uses Epidemiological Methods to discover the cause of Cancer and to recognize and develop improved treatments. This area of study must cope with problems of lead time bias and length time bias. Lead time bias is the theory that early diagnosis may artificially inflate the survival statistics of a Cancer, without really improving the natural history of the disease. Length bias is the concept that gentler growing, more lethargic Tumors are more likely to be identified by Screening Tests, but improvements in diagnosing more cases of indolent Cancer may not translate into better patient outcomes after the implementation of Screening Programs

Prevention or Preventive Healthcare means measures that are taken for Cancer Prevention. Cancer can be prevented by living a healthy lifestyle. A healthy lifestyle and regular screening exams help to reduce your risk for some types of Cancer.

Screenings can find Cancer early, when it’s most treatable. Cancer Screening aims to identify Cancer before symptoms appear. This may involve blood tests, urine tests, other tests, or Medical Imaging. The benefits of screening in terms of Cancer Prevention, early detection and subsequent treatment must be weighed against any harm. Worldwide screening, Population Screening or Mass Screening involves screening everyone, generally within a specific age group. Selective Screening identifies people who are known to be at advanced risk of developing Cancer, such as people with a family history of Cancer.

  • Global trends in Cancer Mortality and Incidence
  • Cancer Epidemiological studies: Principles, Statistics, Methodologies & Reporting
  • Cancer Epidemiological Risk factors
  • Cancer Screening, evaluation and intervention
  • Cancer Staging
  • Early detection and diagnosis of Cancer
  • Cohort studies and Cancer Survival analysis

Related Conference of Cancer Epidemiology, Screening & Prevention

October 03-04, 2018

10th Annual Congress on Biomarkers, Clinical Research
& Therapeutics

Los Angeles, California, USA
October 11-13, 2018

36th World Cancer Conference

Venue: Hilton Zurich Airport, Hohenbühlstrasse 10, 8152 Opfikon, Switzerland
October 18-19, 2018

Euro Oncology Summit

| Amsterdam, Netherlands
October 18-19, 2018

14th Global Biomarkers Summit

| Amsterdam, Netherlands
October 18-19, 2018

9th Euro Breast Cancer Summit

| Amsterdam, Netherlands
October 26-27, 2018

International Conference on Robotic Oncology

Osaka, Japan
October 29-30, 2018

International Conference on Gastrointestinal Cancer and Therapeutics

San Francisco, California, USA
October 29-30, 2018

26th Annual Congress on Cancer Science and Targeted Therapies

San Francisco, California, USA
November 14-15, 2018

International Conference on Cancer Science & Robotics

Melbourne, Australia
November 14-15, 2018

30th Experts Meet On Cancer Therapy

Melbourne, Australia
November 29-30, 2018

13th World Biomarkers Congress

Dublin, Ireland
November 29-December 01, 2018

3rd Cancer Diagnostics & Treatment Conference

Dublin, Ireland
March 07-08, 2019

32nd Euro Congress on Cancer Science & Therapy

Barcelona, Spain
April 04-05, 2019

23rd Global Annual Oncologists Meeting

Auckland, New Zealand
April 08-09, 2019

3 rd World Congress on Radiology and Oncology

Abu Dhabi, UAE
April 29-30, 2019

33rd Global Experts Meeting onCancer Science & Therapy

Seoul, South Korea
May 6-7, 2019

3rd Global Summit on Oncology & Cancer

Tokyo, Japan
May 09-10, 2019

15th World Congress on Blood Cancer

Amsterdam, Netherlands
August 22-23, 2019

5th International Congress on Epigenetics & Chromatin

Vienna, Austria

Cancer Epidemiology, Screening & Prevention Conference Speakers

Recommended Sessions

Related Journals

Are you interested in